Search All Patents in Cannabis: Compositions
Patent US10688191
Issued 2020-06-23
Delivery Of A Chemotherapy Agent Across The Blood-brain Barrier
A therapeutic method and composition which includes a cannabinoid chemically linked to a chemotherapy agent. The therapeutic composition is capable of crossing the blood-brain barrier, and delivery of the composition across the blood-brain barrier provides both chemotherapy for the treatment of brain cancer and alleviation of side effects caused by the chemotherapy agent. Once across the blood-brain barrier, the chemotherapy agent will be released to attack cancer cells, and the cannabinoid will be free to bind to cannabinoid receptors in the brain to alleviate side effects of chemotherapy such as nausea/vomiting, pain and decreased appetite.
Much More than Average Length Specification
View the Patent Matrix® Diagram to Explore the Claim Relationships
USPTO Full Text Publication >
- 1. A therapeutic composition capable of crossing the blood-brain barrier, the composition comprising a chemotherapy agent for the treatment of brain cancer and a cannabinoid for alleviation of side effects caused by the chemotherapy agent, wherein the chemotherapy agent is chemically linked to the cannabinoid, and wherein the cannabinoid is tetrahydrocannabivarin and the chemotherapy agent is Carmustine.
- 6. A therapeutic composition for the treatment of brain cancer, the composition comprising:
a. a cannabinoid; and b. a chemotherapy agent, wherein the cannabinoid and the chemotherapy agent are chemically linked, wherein the composition is capable of crossing the blood-brain barrier to provide both chemotherapy for the treatment of brain cancer and alleviation of side effects caused by chemotherapy, and wherein the cannabinoid is tetrahydrocannabivarin and the chemotherapy agent is Carmustine.
